Hematology
Senior Consultant & HOD – Hemato-Oncology, Bone Marrow Transplantation and Cellular Therapy15 Years of Experience in Hematology, Hemato-Oncology and Bone Marrow Transplantation
HCG Cancer Hospital, K R Road
Bangalore
Dr. Nataraj K S is a senior Hematologist, Hemato-Oncologist and Bone Marrow Transplant physician in Bengaluru with 15 years of specialist experience in the management of blood disorders, blood cancers and stem cell transplantation.
His major areas of expertise include leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, aplastic anemia and other malignant and non-malignant hematological disorders affecting both adults and children.
Dr. Nataraj K S has extensive experience in autologous and allogeneic stem cell transplantation, including matched sibling, matched unrelated, mismatched and haploidentical donor transplantation. He is also involved in CAR-T cell and other advanced cellular therapies for selected relapsed or difficult-to-treat blood cancers.
He completed MBBS, MD in Internal Medicine and DM in Hematology, Hemato-Oncology and Bone Marrow Transplantation. He is also an EBMT Certified Transplant Physician and holds an honorary FRCP from Glasgow.
Dr. Nataraj K S currently serves as Senior Consultant and Head of Hemato-Oncology and Bone Marrow Transplantation at HCG in Bengaluru and is actively involved in clinical trials, postgraduate teaching and research in hematology and cellular therapy.
Leukemia treatment is planned according to the type of leukemia, disease risk, genetic findings, treatment response and overall health of the patient.
Lymphoma treatment depends on the lymphoma subtype, disease stage and biological characteristics and may include systemic therapy, cellular therapy or stem cell transplantation.
Multiple myeloma management may involve systemic therapy, targeted treatment and autologous stem cell transplantation in appropriately selected patients.
Myelodysplastic syndrome management is based on disease risk, blood counts, cytogenetic findings and the patient's overall condition, with stem cell transplantation considered in selected cases.
Aplastic anemia treatment may include supportive care, immunosuppressive therapy or stem cell transplantation depending on severity, age and donor availability.
Thalassemia care includes long-term hematology monitoring, transfusion support and consideration of curative stem cell transplantation in suitable patients.
Hemophilia management focuses on preventing and treating bleeding episodes through specialised hematology care and appropriate clotting factor or related therapies.
Autologous transplantation uses the patient's own collected stem cells and is commonly used in selected blood cancers such as multiple myeloma and lymphoma.
Allogeneic transplantation uses stem cells from a compatible donor and may be used for leukemia, aplastic anemia, myelodysplastic syndromes and other hematological conditions.
Haploidentical transplantation uses a partially matched family donor and can expand transplant options when a fully matched donor is not available.
Matched unrelated donor transplantation uses stem cells from a genetically compatible unrelated donor for selected hematological diseases.
Mismatched donor transplantation may be considered in selected patients when a fully matched donor is unavailable and requires specialised transplant expertise.
CAR-T cell therapy is an advanced cellular treatment in which a patient's T cells are modified to recognise and attack specific cancer cells in selected blood cancers.
Post-transplant care includes monitoring and treatment of infections, graft-related complications, immune problems and long-term effects following stem cell transplantation.
MBBS, MD (Internal Medicine), DM (Hematology, Hemato-Oncology and BMT), EBMT Certified Transplant Physician, FRCP (Glasgow) (Hons)
Leukemia Treatment, Lymphoma Treatment, Multiple Myeloma Treatment, Myelodysplastic Syndrome Treatment, Aplastic Anemia Treatment, Thalassemia Treatment, Hemophilia Management, Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Haploidentical Stem Cell Transplantation, Matched Unrelated Donor Transplantation, Mismatched Donor Transplantation, CAR-T Cell Therapy, Post-Transplant Complication Management
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Nataraj K S
HCG currently states that Dr. Nataraj K S has performed more than 1,500 stem cell transplants, with approximately 70% being allogeneic transplants.
Yes. Leukemia, lymphoma, multiple myeloma, aplastic anemia and myelodysplastic syndrome are among Dr. Nataraj K S's main documented clinical interests.
Yes. CAR-T cell therapy is one of Dr. Nataraj K S's documented advanced areas of expertise for selected blood cancers.
Yes. Dr. Nataraj K S has extensive experience in autologous and allogeneic stem cell transplantation, including matched, unrelated, mismatched and haploidentical donor transplants.
Dr. Nataraj K S's qualifications include MBBS, MD in Internal Medicine, DM in Hematology, Hemato-Oncology and BMT, EBMT Certified Transplant Physician certification and honorary FRCP from Glasgow.
Contact us for personalized help or to schedule an appointment.